MAX-001

N/A

Report date: 2025/11/05 15:24:27
NME

Base Information

Drug NameMAX-001
Drug Alias NameMAX-001MAX001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed cell death protein 1 inhibitorsProgrammed death-ligand 1 blockersCyclooxygenase-2 inhibitors
TargetsProgrammed death-ligand 1Programmed cell death protein 1Cyclooxygenase-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInflamax Pharmaceuticals (Guangzhou) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInflamax Pharmaceuticals (Guangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A